Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies

Autor: Tuzmen, Ceren, Cairns, Tina M., Atanasiu, Doina, Lou, Huan, Saw, Wan Ting, Hall, Bonnie L., Cohen, Justus B., Cohen, Gary H., Glorioso, Joseph C.
Zdroj: In Molecular Therapy - Methods & Clinical Development 13 March 2020 16:145-154
Databáze: ScienceDirect